Global Gout Therapeutics Market is Segmented by Drug class type (Antihyperuricemic Agents, Non-steroidal Anti-inflammatory Drugs, Corticosteroids, Colchicine, Other Drug Classes); by Application type (Acute Gout and Chronic Gout), Regional Forecasts 2021-2027
- Category: Healthcare
- Published Date: Oct 2021
- Publisher: Bizwit Research
- Pages: 200
Global Gout Therapeutics Market is valued approximately at USD XX billion in 2020 and is projected to grow with a healthy growth rate of more than 15.5% over the forecast period 2021-2028. Gout is a regular form of inflammatory arthritis that is very painful in long term. It usually affects one joint at a time. Many of times the symptoms get worse, called flares, and sometimes, there are no symptoms, known as remission. Though, there is no cure for gout, but you can effectively treat and manage the condition with a change in lifestyles, medication, and self-management strategies. The risk of gout increases when alcohol intake goes up. The key driving factors contributing to growth of Gout Therapeutics Market are growing adoption of biologics, increasing R&D on regenerative drugs for treatment and rising prevalence of gout with increasing alcohol consumption. For instance, as per the Australian Bureau of Statistics and National Health Survey 2017-2018, It has been estimated that 0.8% of total population) suffer from gout condition. It has been also found that Gout is more common in males than females, 9 out of 10 people suffered with gout are males. Hence, considering above all factors the market is expected to show growth in the near future. It has been seen that increasing occurrence of gout across the world is due to change in lifestyles patterns are likely to boost the market in the upcoming years. Increasing alcohol consumption, high purine diet, rising patient pool, rising obesity & kidney diseases among people, and rising consumption of certain medications such as diuretics could further increase the incidence of gout. Despite this, there are potential side-effects of most existing gout therapeutic drugs and high indirect cost for gout therapeutics. Hence, these factors could hamper the growth of the market in the long run.
Asia Pacific region is expanding its presence and is expected to observe the fastest growth over the forecasted period due to continuous increasing patients, rising adoption of gout therapies, rising investment by major operating players in this region. Furthermore, the increasing alcohol consumption & smoking habits and stressed lifestyles are likely to boost the gout therapeutics market during the forecast period.
Major market player included in this report are
Lannett Company, Inc
Boehringer Ingelheim
GlaxoSmithKline PLC
Horizon Therapeutics plc
Mylan NV
Novartis International AG
Regeneron Pharmaceuticals
Romeg Therapeutics, LLC.
Takeda Pharmaceutical Company Ltd
Teijin Pharma Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug class type:
Antihyperuricemic Agent
Non-steroidal Anti-inflammatory Drugs
Corticosteroids
Colchicine
Other Drug Classes
By Application type:
Acute Gout
Chronic Gout
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Maple Water Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Asia Pacific region is expanding its presence and is expected to observe the fastest growth over the forecasted period due to continuous increasing patients, rising adoption of gout therapies, rising investment by major operating players in this region. Furthermore, the increasing alcohol consumption & smoking habits and stressed lifestyles are likely to boost the gout therapeutics market during the forecast period.
Major market player included in this report are
Lannett Company, Inc
Boehringer Ingelheim
GlaxoSmithKline PLC
Horizon Therapeutics plc
Mylan NV
Novartis International AG
Regeneron Pharmaceuticals
Romeg Therapeutics, LLC.
Takeda Pharmaceutical Company Ltd
Teijin Pharma Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug class type:
Antihyperuricemic Agent
Non-steroidal Anti-inflammatory Drugs
Corticosteroids
Colchicine
Other Drug Classes
By Application type:
Acute Gout
Chronic Gout
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Maple Water Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Gout Therapeutic Market, by region, 2019-2027 (USD Billion)
1.2.2. Gout Therapeutic Market, by Drug Class type, 2019-2027 (USD Billion)
1.2.3. Gout Therapeutic Market, by Application type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Gout Therapeutic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Gout Therapeutic Market Dynamics
3.1. Gout Therapeutic Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing Adoption of Biologics and Increasing R&D
3.1.1.2. Rising Prevalence of Gout with Increasing Alcohol Consumption
3.1.2. Market Restraint
3.1.2.1. Changing lifestyles and high purine diet
3.1.2.2. Rising patient pool
3.1.3. Market Opportunities
3.1.3.1. Potential side-effects of most existing gout therapeutic drugs
3.1.3.2. high indirect costs for therapy
Chapter 4. Global Gout Therapeutic Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Gout Therapeutic Market, by Drug Class type
5.1. Market Snapshot
5.2. Global Gout Therapeutic Market by Drug Class type, Performance - Potential Analysis
5.3. Global Gout Therapeutic Market Estimates & Forecasts by Drug Class type 2018-2027 (USD Billion)
5.4. Gout Therapeutic Market, Sub Segment Analysis
5.4.1. Antihyperuricemic Agents
5.4.2. Non-steroidal Anti-inflammatory Drugs
5.4.3. Corticosteroids
5.4.4. Colchicine
5.4.5. Other Drug Classes
Chapter 6. Global Gout Therapeutic Market, by Application type
6.1. Market Snapshot
6.2. Global Gout Therapeutic Market by Application type, Performance - Potential Analysis
6.3. Global Gout Therapeutic Market Estimates & Forecasts by Application type 2018-2027 (USD Billion)
6.4. Gout Therapeutic Market, Sub Segment Analysis
6.4.1. Acute Gout
6.4.2. Chronic Gout
Chapter 7. Global Gout Therapeutic Market, Regional Analysis
7.1. Gout Therapeutic Market, Regional Market Snapshot
7.2. North America Gout Therapeutic Market
7.2.1. U.S. Gout Therapeutic Market
7.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
7.2.1.2. Application type breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Gout Therapeutic Market
7.3. Europe Gout Therapeutic Market Snapshot
7.3.1. U.K. Gout Therapeutic Market
7.3.2. Germany Gout Therapeutic Market
7.3.3. France Gout Therapeutic Market
7.3.4. Spain Gout Therapeutic Market
7.3.5. Italy Gout Therapeutic Market
7.3.6. Rest of Europe Gout Therapeutic Market
7.4. Asia-Pacific Gout Therapeutic Market Snapshot
7.4.1. China Gout Therapeutic Market
7.4.2. India Gout Therapeutic Market
7.4.3. Japan Gout Therapeutic Market
7.4.4. Australia Gout Therapeutic Market
7.4.5. South Korea Gout Therapeutic Market
7.4.6. Rest of Asia Pacific Gout Therapeutic Market
7.5. Latin America Gout Therapeutic Market Snapshot
7.5.1. Brazil Gout Therapeutic Market
7.5.2. Mexico Gout Therapeutic Market
7.6. Rest of The World Gout Therapeutic Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Lannett Company, Inc
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Boehringer Ingelheim
8.2.3. GlaxoSmithKline PLC
8.2.4. Horizon Therapeutic Plc
8.2.5. Mylan NV
8.2.6. Novartis International AG
8.2.7. Regeneron Therapeutical
8.2.8. Takeda Pharmaceutical company Ltd
8.2.9. Teijin Pharma Ltd.
8.2.10. Romeg Therapeutics, LLC.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Gout Therapeutic Market, by region, 2019-2027 (USD Billion)
1.2.2. Gout Therapeutic Market, by Drug Class type, 2019-2027 (USD Billion)
1.2.3. Gout Therapeutic Market, by Application type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Gout Therapeutic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Gout Therapeutic Market Dynamics
3.1. Gout Therapeutic Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing Adoption of Biologics and Increasing R&D
3.1.1.2. Rising Prevalence of Gout with Increasing Alcohol Consumption
3.1.2. Market Restraint
3.1.2.1. Changing lifestyles and high purine diet
3.1.2.2. Rising patient pool
3.1.3. Market Opportunities
3.1.3.1. Potential side-effects of most existing gout therapeutic drugs
3.1.3.2. high indirect costs for therapy
Chapter 4. Global Gout Therapeutic Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Gout Therapeutic Market, by Drug Class type
5.1. Market Snapshot
5.2. Global Gout Therapeutic Market by Drug Class type, Performance - Potential Analysis
5.3. Global Gout Therapeutic Market Estimates & Forecasts by Drug Class type 2018-2027 (USD Billion)
5.4. Gout Therapeutic Market, Sub Segment Analysis
5.4.1. Antihyperuricemic Agents
5.4.2. Non-steroidal Anti-inflammatory Drugs
5.4.3. Corticosteroids
5.4.4. Colchicine
5.4.5. Other Drug Classes
Chapter 6. Global Gout Therapeutic Market, by Application type
6.1. Market Snapshot
6.2. Global Gout Therapeutic Market by Application type, Performance - Potential Analysis
6.3. Global Gout Therapeutic Market Estimates & Forecasts by Application type 2018-2027 (USD Billion)
6.4. Gout Therapeutic Market, Sub Segment Analysis
6.4.1. Acute Gout
6.4.2. Chronic Gout
Chapter 7. Global Gout Therapeutic Market, Regional Analysis
7.1. Gout Therapeutic Market, Regional Market Snapshot
7.2. North America Gout Therapeutic Market
7.2.1. U.S. Gout Therapeutic Market
7.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
7.2.1.2. Application type breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Gout Therapeutic Market
7.3. Europe Gout Therapeutic Market Snapshot
7.3.1. U.K. Gout Therapeutic Market
7.3.2. Germany Gout Therapeutic Market
7.3.3. France Gout Therapeutic Market
7.3.4. Spain Gout Therapeutic Market
7.3.5. Italy Gout Therapeutic Market
7.3.6. Rest of Europe Gout Therapeutic Market
7.4. Asia-Pacific Gout Therapeutic Market Snapshot
7.4.1. China Gout Therapeutic Market
7.4.2. India Gout Therapeutic Market
7.4.3. Japan Gout Therapeutic Market
7.4.4. Australia Gout Therapeutic Market
7.4.5. South Korea Gout Therapeutic Market
7.4.6. Rest of Asia Pacific Gout Therapeutic Market
7.5. Latin America Gout Therapeutic Market Snapshot
7.5.1. Brazil Gout Therapeutic Market
7.5.2. Mexico Gout Therapeutic Market
7.6. Rest of The World Gout Therapeutic Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Lannett Company, Inc
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Boehringer Ingelheim
8.2.3. GlaxoSmithKline PLC
8.2.4. Horizon Therapeutic Plc
8.2.5. Mylan NV
8.2.6. Novartis International AG
8.2.7. Regeneron Therapeutical
8.2.8. Takeda Pharmaceutical company Ltd
8.2.9. Teijin Pharma Ltd.
8.2.10. Romeg Therapeutics, LLC.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
no record found